The European Parliament has overwhelmingly adopted the Special Committee on Beating Cancer (BECA) report in a move that marks the first time a European institution has formally acknowledged reduced risk products could play a role in smoking cessation – with some caveats.
The parliament voted 652 in favour, 15 against and 27 abstaining during last week’s plenary session. The approved plan included “compromise amendments” on alternatives approved by 29 of 34 committee members in December.
